Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/12/24 18:23 | 2/8/24 | JSPR | Financ | InvAdv | Investment Advice | Carlyle Group Inc. | DC | H | Former 1 | P | 2,461 | 12.95 | 0 | 190 | 22 | 1,066 | I | ||||||||||||||
2/9/24 20:40 | 2/8/24 | JSPR | Health | BioPrd | Biological Products, (No Diag | Velan Capital Investment Management LP | GA | T | P | 4,533 | 12.95 | 0 | 350 | 32 | 1,434 | I | |||||||||||||||
11/30/23 16:05 | 11/28/23 | JSPR | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | P | 6 | 0.6486 | 0 | 10 | 25 | 50 | D | |||||||||||||||
11/22/23 16:06 | 11/21/23 | JSPR | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | P | 6 | 0.6383 | 0 | 10 | 33 | 40 | D | |||||||||||||||
11/20/23 20:14 | 11/16/23 | JSPR | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | P.m | 18 | 0.6080 | 0 | 30 | New | 30 | D | |||||||||||||||
4/11/23 19:55 | 1/27/23 | JSPR | Health | BioPrd | Biological Products, (No Diag | Qiming U.S. Healthcare Fund Ii, L.P. | WA | T | P | 4,000 | 1.50 | 0 | 2,667 | 46 | 8,520 | D | |||||||||||||||
1/31/23 17:24 | 1/27/23 | JSPR | Financ | InvAdv | Investment Advice | Carlyle Group Inc. | DC | T | P | 4,700 | 1.50 | 0 | 3,133 | 56 | 8,762 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |